Dr. Deligiannidis is the Director of Women’s Behavioral Health (WBH) at Zucker Hillside Hospital, Northwell Health. Dr. Deligiannidis received her medical degree from and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School (2009). Prior to and during medical school she trained in neuroscience research at the National Institutes of Health (NIH). After residency she completed additional research training in behavioral endocrinology and experimental therapeutics at the NIH and in neuroimaging at Harvard/MIT.

As Director of WBH, Dr. Deligiannidis leads a federally-funded clinical/translational research program in perinatal depression and leads the perinatal clinical care and training programs at Zucker Hillside Hospital. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle, perinatal and perimenopausal periods. She is a nationally-recognized leader in the field of perinatal depression and in novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and multimodal neuroimaging in perinatal depression. Dr. Deligiannidis’s research is supported by NIH, foundation and industry funding, including prestigious K23 and R01 grants. Her efforts have been nationally recognized with many awards for research and medical student and resident teaching. She has published numerous manuscripts and has given many oral presentations/research posters at local, national and international scientific conferences. Her research has been covered by major media outlets, including CNN, the Associated Press, National Public Radio, the Boston Globe, Boston ABC and CBS News, CBS and ABC-New York, Good Morning America, Time Magazine and others. Her work over the past 12 years was recognized with the 2019 Northwell Health Truly Award for Innovation (awarded to 1 of 7,000 physicians) and she was 1 of 9 Northwell Health Physicians of the Year in 2020.

Dr. Deligiannidis actively contributes to national scientific committees. She is a Council member of the Society of Biological Psychiatry and a full Member of the American College of Neuropsychopharmacology where she serves on several committees. Dr. Deligiannidis also serves as a reviewer on over 20 scientific journals and on Editorial Boards of national and international journals. Thrice annually she serves as a federal grant reviewer for the Center for Scientific Review at NIH. Locally she serves on steering committees in both the Departments of Obstetrics & Gynecology and Psychiatry at Long Island Jewish Medical Center and Zucker Hillside Hospital and at the Katz Institute for Women’s Health on Long Island. She additionally serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell.